文献速递主动脉疾病

「Octafen」:一种非研究性替代覆膜支架构型用于胸腹主动脉瘤治疗

"Octafen": A Noninvestigational Alternative Endograft Configuration for the Treatment of Thoracoabdominal Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2022-07-22

本文介绍 Octafen 技术,即联合市售分支型 EVAR 装置(Excluder)与双肾动脉开窗装置(Z-Fen)治疗胸腹主动脉瘤的新构型,为 Octopus 技术的改良。两例复杂胸腹主动脉瘤且外科高风险患者在杂交手术室经 CT-荧光透视三维融合引导下接受该构型治疗,技术可行,可规避对定制研究性装置的依赖。

要点

  • Octafen 技术联合市售 Excluder 分支型 EVAR 装置与 Z-Fen 双肾动脉开窗装置治疗胸腹主动脉瘤。
  • 两例复杂胸腹主动脉瘤且外科高风险患者经 CT-荧光透视三维融合引导完成该构型治疗。
  • 该技术为无法获取研究性装置、时间紧迫或无法开放手术的患者提供替代选择。

核心结论

  • Octafen 技术可能为胸腹主动脉瘤治疗提供一种替代选择,规避获取定制研究性装置的需求。

研究设计与样本

  • 本文为技术描述,报告两例复杂胸腹主动脉瘤且外科高风险患者接受 Octafen 覆膜支架构型治疗。

主要发现

  • 两例复杂胸腹主动脉瘤且外科高风险患者在杂交手术室经 CT-荧光透视图像融合引导、使用三维-三维融合技术接受 Octafen 构型治疗。
  • Octafen 技术为既往描述的 Octopus 胸腹主动脉瘤腔内修复技术的改良。
  • 该技术的主要优势为可联合市售装置与非研究性定制装置修复胸腹主动脉瘤。

关键数值与推荐

  • 所用装置为市售分支型 EVAR 装置(Excluder;W.L. Gore & Associates,Flagstaff,Arizona)联合双肾动脉开窗装置(Z-Fen;Cook Medical,Bloomington,Indiana)。

临床怎么用

  • 在无法获取研究性装置、时间紧迫的病例以及无法接受开放手术的功能储备有限患者中,该技术可提供替代治疗。
  • 所用装置对大多数执业血管外科医生而言易于获得。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To demonstrate the feasibility of Octafen technique, a novel endovascular configuration for the treatment of thoracoabdominal aortic aneurysms (TAAA). TECHNIQUE: Two patients with complex TAAA and high surgical risk were treated with Octafen endograft configuration in a hybrid operating room with computed tomography (CT)-fluoroscopy image fusion guidance, using 3D-3D fusion techniques to facilitate procedural success. The procedure is a modification of the previously-described Octopus technique for endovascular repair of TAAA. The main advantage of this technique is the ability to use devices to repair a TAAA with the combination of off-the-shelf and noninvestigational custom-made devices. The devices used are readily available to most practicing vascular surgeons, which provides an alternative treatment in case of limited access to investigational devices, in time-sensitive cases, and in patients with limited functional capacity who cannot undergo open repair. In the modification described herein, we use a combination of standard bifurcated endovascular aneurysm repair (EVAR) devices (Excluder; W.L. Gore & Associates, Flagstaff, Arizona) in combination with a 2-vessel renal fenestrated device (Z-Fen; Cook Medical, Bloomington, Indiana). The article describes a step-by-step approach to this technique to elucidate pitfalls, benefits, and advantages. CONCLUSION: The Octafen technique might offer an alternative option for thoracoabdominal aneurysm treatment circumventing the need for access to custom-made, investigational devices. CLINICAL IMPACT: In this manuscript, we describe a technique for endovascular repair of thoraco-abdominal aortic aneurysms that involves the combination of off-the-shelf and non-investigational, custom-made devices. The 'Octafen' technique provides a treatment alternative in case of limited access to investigational devices and can be adjusted according to patient anatomy.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Katsarou M, Auyang PL, Chinnadurai P, et al. "Octafen": A Noninvestigational Alternative Endograft Configuration for the Treatment of Thoracoabdominal Aortic Aneurysms. J Endovasc Ther. 2022. PMID: 35869618. doi:10.1177/15266028221113752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。